<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01365195</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00024533</org_study_id>
    <nct_id>NCT01365195</nct_id>
  </id_info>
  <brief_title>Effect of Ketamine on Postoperative Clinical Outcomes</brief_title>
  <official_title>Intraoperative Ketamine Administration in Colorectal Surgery: Effect on Postoperative Clinical Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cedars-Sinai Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cedars-Sinai Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to evaluate the effectiveness of ketamine as an analgesic
      adjuvant in decreasing the narcotic (opioids) analgesics during surgery, on pain management
      and on the later recovery after surgery in patients undergoing colorectal surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Adjuvant is a drug that has few or no pharmacological effects by itself, but may increase the
      effectiveness or strength of other drugs when given at the same time.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">March 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Opioid consumption obtained from the recorded data</measure>
    <time_frame>1 month</time_frame>
    <description>Perioperative use of opioid consumption inside hospital (recorded by study staff and data obtained from patient charts) Post discharge use of opioid consumption (data obtained from the follow up questionnaires approximately one week after surgery).
And from the next postoperative visit (one month) after surgery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain using a Verbal Rating Scale</measure>
    <time_frame>one month</time_frame>
    <description>Postoperative will be measured at PACU, one week after surgery and at the next postoperative vist (one month) after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nausea and vomiting will be measured with follow up</measure>
    <time_frame>1 month</time_frame>
    <description>Postoperative nausea and vomiting using a Verbal Rating Scale (0-10) at PACU, one week after surgery and at the next postoperative vist (one month) after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Constipation (Ileus)</measure>
    <time_frame>1 month</time_frame>
    <description>at PACU, one week after surgery and at the next postoperative vist (one month) after surgery.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">102</enrollment>
  <condition>Colorectal Surgery</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Loading and Infusion:
Saline at infusion rate calculated and adjusted for weight to match ketamine bolus-infusion rate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ketamine low-dose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Loading: 0.5 mg/Kg Infusion: 5 mcg/kg/min</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ketamine high-dose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Loading: 1 mg/Kg Infusion: 10 mcg/kg/min</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Loading and Infusion: Saline at infusion rate calculated and adjusted for weight to match ketamine bolus-infusion rate</description>
    <arm_group_label>Ketamine low-dose</arm_group_label>
    <arm_group_label>Ketamine high-dose</arm_group_label>
    <other_name>Saline Solution</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine high-dose</intervention_name>
    <description>Loading: 1 mg/Kg Infusion: 10 mcg/kg/min</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Ketamine low-dose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine low-dose</intervention_name>
    <description>Loading: 0.5 mg/Kg Infusion: 5 mcg/kg/min</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Ketamine high-dose</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          1. Patients scheduled to undergo small and/or large partial bowel resection via
             laparotomy or laparoscopy

          2. Willingness and ability to sign an informed consent document

          3. No allergies to anesthetic or analgesic medications

          4. 18 - 80 years of age

          5. American Society of Anesthesiologists (ASA) Class I - III adults of either sex

        Exclusion Criteria

          1. Inability to comprehend the pain assessment tools

          2. Patients with known allergy, hypersensitivity or contraindications to anesthetic or
             analgesic medications

          3. Patients with clinically-significant heart disease including arrhythmias and
             significant hypertension, brain aneurysms, prior history of cerebral vascular accident
             (CVA), or chronic renal insufficiency

          4. Prior abdominal surgery

          5. History of abdominal carcinomatosis

          6. History of radiation enteritis;

          7. Patients with history of hepatic, renal, cardiac failure, organ transplant, or
             diabetes

          8. Patients with seizures

          9. Morbid obesity (body mass index &gt;40)

         10. Pregnant or lactating women

         11. Subjects with a history of alcohol or drug abuse within the past 3 months

         12. Any other conditions or use of any medication which may interfere with the conduct of
             the study

         13. Prophylactic Nasogastric Tube (NGT) use

         14. Individuals with significant manic disorders including: schizophrenia, or bipolar
             disorder or psychosis

         15. Individuals with asthma and/or thyroid diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roya Yumul, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cedars-Sinai Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Roya Yumul, MD., PhD</last_name>
    <role>Study Director</role>
    <affiliation>Cedars-Sinai Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cedars Sinai Medical center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 1, 2011</study_first_submitted>
  <study_first_submitted_qc>June 1, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2011</study_first_posted>
  <last_update_submitted>April 3, 2018</last_update_submitted>
  <last_update_submitted_qc>April 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cedars-Sinai Medical Center</investigator_affiliation>
    <investigator_full_name>Roya Yumul, M.D.,PhD.</investigator_full_name>
    <investigator_title>Residency program director, Department of anesthesiology</investigator_title>
  </responsible_party>
  <keyword>opioid</keyword>
  <keyword>Fentanyl</keyword>
  <keyword>Anesthetic adjuvant</keyword>
  <keyword>Pain management</keyword>
  <keyword>Perioperative outcomes</keyword>
  <keyword>Constipation</keyword>
  <keyword>Ileus</keyword>
  <keyword>Colorectal</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

